Private Market View

Juwei Yuanchuang Biotechnology

Suzhou, China · Founded 2018 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
$1.6M
Last round

Key facts

  • It has raised $1.6M; the latest was Later Stage VC in Apr 2025.
  • Notable investors include CMB International Capital, GF Xinde Investment Management, Taiyou Fund, Lianyungang Jinhai Venture Capital, Jiangsu Coast Development Group15 tracked in total.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 15 names
  • ·Watchlist + deal alerts for Juwei Yuanchuang Biotechnology
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Juwei Yuanchuang Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Juwei Yuanchuang Biotechnology

Developer of biological transformation technology designed to produce the entire chain of straw saccharification. The company is committed to the biological transformation and efficient utilization of non-grain biomass that converting common agricultural and animal husbandry wastes into fermentation raw materials, enabling clients to promote the large-scale development of the non-grain biomanufacturing industry.

Sector
Materials and Resources
HQ
Suzhou, China
Founded
2018
Ownership
Privately Held (backing)
PA Mark — not yet priced

Juwei Yuanchuang Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Juwei Yuanchuang Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Juwei Yuanchuang Biotechnology in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.